Cytokinetics

$24.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.12%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Cytokinetics and other stocks, options, and ETFs commission-free!

About CYTK

Cytokinetics, Inc. operates as a biopharmaceutical company. The firm focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases.

CEO

Robert I. Blum

Employees

184

Headquarters

South San Francisco, California

Founded

1997

Market Cap

1.72B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

683.63K

High Today

$24.51

Low Today

$23.54

Open Price

$24.00

Volume

598.04K

52 Week High

$30.14

52 Week Low

$13.08

Analyst Ratings

91%

of 11 ratings

Buy

91%

Hold

Sell

CYTK Earnings

-$0.68

-$0.45

-$0.23

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 5, After Hours